ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $114,000 | -43.3% | 9,500 | 0.0% | 0.03% | -49.1% |
| Q2 2021 | $201,000 | -24.4% | 9,500 | 0.0% | 0.05% | -24.3% |
| Q1 2021 | $266,000 | +7.7% | 9,500 | 0.0% | 0.07% | +4.5% |
| Q4 2020 | $247,000 | -30.0% | 9,500 | 0.0% | 0.07% | -41.2% |
| Q3 2020 | $353,000 | -21.9% | 9,500 | 0.0% | 0.11% | -24.0% |
| Q2 2020 | $452,000 | +51.7% | 9,500 | 0.0% | 0.15% | +10.3% |
| Q1 2020 | $298,000 | -83.3% | 9,500 | -68.3% | 0.14% | -78.9% |
| Q4 2019 | $1,787,000 | +147.2% | 30,000 | +200.0% | 0.64% | +128.4% |
| Q1 2018 | $723,000 | – | 10,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |